Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids

The generation of oxidized phospholipids in lipoproteins has been linked to vascular inflammation in atherosclerotic lesions. Products of phospholipid oxidation increase endothelial activation; however, their effects on macrophages are poorly understood, and it is unclear whether these effects are regulated by the biochemical pathways that metabolize oxidized phospholipids. We found that incubation of 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC) with THP-1-derived macrophages upregulated the expression of cytokine genes, including granulocyte/macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor (TNF)-α, monocyte chemotactic protein 1 (MCP-1), interleukin (IL)-1β, IL-6, and IL-8. In these cells, reagent POVPC was either hydrolyzed to lyso-phosphatidylcholine (lyso-PC) or reduced to 1-palmitoyl-2-(5-hydroxy-valeroyl)-sn-glycero-3-phosphocholine (PHVPC). Treatment with the phospholipase A2 (PLA2) inhibitor, pefabloc, decreased POVPC hydrolysis and increased PHVPC accumulation. Pefabloc also increased the induction of cytokine genes in POVPC-treated cells. In contrast, PHVPC accumulation and cytokine production were decreased upon treatment with the aldose reductase (AR) inhibitor, tolrestat. In comparison with POVPC, lyso-PC led to 2- to 3-fold greater and PHVPC 10- to 100-fold greater induction of cytokine genes. POVPC-induced cytokine gene induction was prevented in bone-marrow derived macrophages from AR-null mice. These results indicate that although hydrolysis is the major pathway of metabolism, reduction further increases the proinflammatory responses to POVPC. Thus, vascular inflammation in atherosclerotic lesions is likely to be regulated by metabolism of phospholipid aldehydes in macrophages. The generation of oxidized phospholipids in lipoproteins has been linked to vascular inflammation in atherosclerotic lesions. Products of phospholipid oxidation increase endothelial activation; however, their effects on macrophages are poorly understood, and it is unclear whether these effects are regulated by the biochemical pathways that metabolize oxidized phospholipids. We found that incubation of 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC) with THP-1-derived macrophages upregulated the expression of cytokine genes, including granulocyte/macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor (TNF)-α, monocyte chemotactic protein 1 (MCP-1), interleukin (IL)-1β, IL-6, and IL-8. In these cells, reagent POVPC was either hydrolyzed to lyso-phosphatidylcholine (lyso-PC) or reduced to 1-palmitoyl-2-(5-hydroxy-valeroyl)-sn-glycero-3-phosphocholine (PHVPC). Treatment with the phospholipase A2 (PLA2) inhibitor, pefabloc, decreased POVPC hydrolysis and increased PHVPC accumulation. Pefabloc also increased the induction of cytokine genes in POVPC-treated cells. In contrast, PHVPC accumulation and cytokine production were decreased upon treatment with the aldose reductase (AR) inhibitor, tolrestat. In comparison with POVPC, lyso-PC led to 2- to 3-fold greater and PHVPC 10- to 100-fold greater induction of cytokine genes. POVPC-induced cytokine gene induction was prevented in bone-marrow derived macrophages from AR-null mice. These results indicate that although hydrolysis is the major pathway of metabolism, reduction further increases the proinflammatory responses to POVPC. Thus, vascular inflammation in atherosclerotic lesions is likely to be regulated by metabolism of phospholipid aldehydes in macrophages. Cardiovascular diseases have become the leading cause of death in the world. A majority of cardiovascular diseases are due to atherosclerosis, which is underlying pathology associated with 70-75% of all cardiovascular deaths (1.Lloyd-Jones D. Adams R.J. Brown T.M. Carnethon M. Dai S. De Simone G. Ferguson T.B. Ford E. Furie K. Gillespie C. et al.Heart disease and stroke statistics--2010 update: a report from the American Heart Association.Circulation. 2010; 121: e46-e215Crossref PubMed Scopus (1408) is a associated with the of vascular lesions in and the PubMed Scopus The in a PubMed Scopus these or and to by A in the of is the vascular of by lipoproteins the is that the the lipoproteins which that cause inflammation and monocyte the of these have that of the of oxidized lipoproteins be to the of phospholipid oxidation the S. The of oxidized phospholipids in PubMed Scopus M. S. D. et by of oxidized phospholipids in oxidized that and their in PubMed Scopus of phospholipids results in the generation of In the are that are derived from the oxidation of is the major phospholipid in and the oxidation of results in the of of which 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC) is in the M. S. D. et by of oxidized phospholipids in oxidized that and their in PubMed Scopus POVPC is the phospholipid in and the of is by POVPC G. C. of of oxidized phospholipids. oxidized the PubMed Scopus the that POVPC and phospholipids in These phospholipids have been in oxidized and atherosclerotic lesions of and E. A oxidized in atherosclerotic lesions. of oxidized and PubMed S. E. of to of oxidized lipoproteins from mice. of of oxidized in PubMed Scopus and of POVPC and oxidation in S. E. of to of oxidized lipoproteins from mice. of of oxidized in PubMed Scopus the of with disease S. R.J. and PubMed Scopus and the of and S. S. M. C. S. et phospholipids the and of and and cardiovascular results from the PubMed Scopus that the generation of oxidized phospholipids be linked to disease In POVPC endothelial to M. S. D. et by of oxidized phospholipids in oxidized that and their in PubMed Scopus and it increases the of cytokine genes and S. G. S. C. et in oxidized of monocyte chemotactic and by endothelial PubMed Scopus C. G. G. et oxidized phospholipids endothelial of and PubMed Scopus it a of inflammation the and the of atherosclerotic lesions S. The of oxidized phospholipids in PubMed Scopus by phospholipid oxidation PubMed Scopus of oxidized to in increases vascular inflammation G. C. phospholipids inflammation in PubMed Scopus The of POVPC and phospholipids has been to be due to the of a the is by and a oxidized phospholipids that the aldehydes are reduced by to the reductase M. K. S. and of with phospholipid PubMed Scopus these aldose reductase was found to be in the reduction of the of POVPC to the it is whether metabolism the of phospholipid the was to a of the of in the proinflammatory effects of POVPC in macrophages. We to macrophages these have been to in death and inflammation in 2010; PubMed Scopus results that macrophages to POVPC by the expression of cytokine genes and that the induction of these genes is regulated by the metabolism of POVPC was from and were from POVPC, and were S. M. reduction of PubMed Scopus of the phospholipid aldehydes was by was by or was the and was in of Scopus Pefabloc was from was a from American Products were from and were from was from was from from and from from the American were in with and and in a the cells, was to a of in and were were by the of and AR-null with the the and of a in the induction of cytokine and PubMed Scopus The were in with and in the expression of cytokine genes, the were in in of THP-1-derived macrophages and were in Treatment were in the were in a of the were in in 1 POVPC incubation the were with and in the were from or the A of and PubMed Scopus with the were from the in in and a the was to reagent was by the of The was with which and were and the were by The was by in and a was the or in was and phospholipids were to to the the was and all were were a a of The were and and and was the a of were a of the of and were a of or The of phospholipid was the of the of to that of the the of was The phospholipid was a with a by a and with of 1 in a of 1 by by a The was to the with The of were with a or with a In with POVPC, POVPC the of the the with was to the incubation were from the and the incubation the was in and a was with in The was by and hydrolyzed to of was by The was with lyso-phosphatidylcholine (lyso-PC) to M. K. S. and of with phospholipid PubMed Scopus S. M. reduction of PubMed Scopus to the was hydrolyzed by to was to and with was the was from 1 1 and were in The was in of with and In was and was of a by of increase in gene expression was and of to gene of of to IL-6, granulocyte/macrophage colony-stimulating factor (GM-CSF), and were from were or from and are in were and in with or POVPC was from 1 from and in and were from on in and of and the of were by on was with the of was by of and 1 the was the of and were and were the and A gene was from were genes, and were are were or was that treatment of endothelial with POVPC results in the of proinflammatory by phospholipid oxidation PubMed Scopus the effects of POVPC on macrophages are poorly it has been that POVPC is a of the S. D. The of oxidized to is in by oxidized phospholipids that are associated with the and protein of the PubMed Scopus it is unclear POVPC the expression of cytokine genes in macrophages. the effects of POVPC on the expression of genes in and cytokine THP-1-derived macrophages were with POVPC, and gene expression was a in treatment with POVPC to gene were of genes in POVPC-treated and in of genes in cells. The expression of the genes and was treatment with POVPC led to the of genes, expression was increased the expression of genes was by 1 and in the expression of genes was increased from 10- to The genes were proinflammatory and and the expression of these genes was increased and increases were also in the expression of vascular and these indicate that POVPC a proinflammatory in macrophages by the induction of genes regulated by the factor leading to the of and that and were to POVPC, in these genes to metabolism results and of genes by genes factor necrosis factor 1 factor of gene in 1 protein and protein endothelial factor factor protein genes 1 protein in a POVPC-induced in proinflammatory genes are regulated by metabolism, POVPC metabolism in macrophages. the major POVPC in macrophages and the pathways in their We also the these were with POVPC. the of the were and their phospholipids were by the and and by In cells, phospholipid were was that is or POVPC in these Treatment with POVPC however, led to the of with of POVPC. of incubation with cells, the of POVPC of that of the with of POVPC in the and the that the is incubation led to a further in POVPC and found in the cells, with the that POVPC is from the the cells, of POVPC in of the of that were either or with POVPC or the were in and in and of the was to 1 of incubation in the the were with POVPC in the of the were was and the phospholipids were the and were to The in all was by the to to POVPC and PHVPC and lyso-PC are of reagent lyso-PC POVPC and PHVPC and a phospholipid of macrophages with POVPC The of POVPC. were and by in the of the and of reagent POVPC, and The the of the The is to the of all and are to the and the of POVPC and from lyso-PC of to with and from the from POVPC-treated The of POVPC was by the of with that in THP-1-derived POVPC is reduced (PHVPC). In to to POVPC also be to lyso-PC either or by phospholipase A2 POVPC also be oxidized to was in these cells, that oxidation is a of POVPC in these cells. was in these in the of POVPC and of POVPC led to a increase in the of the of POVPC the phospholipid from the was by and the and were the The and the with of the The to the were and in the and The were to of reagent in the the of the to the of a were found of or of and (lyso-PC) In with the M. of phospholipids by and PubMed Scopus the that of In the with a the of the to their the of the a with which is and to the on the and of the of the POVPC in macrophages to PHVPC and of POVPC led to a increase in the of the with of be to POVPC metabolism, was in the cells. to the of to In 1 of the was hydrolysis by be to in the of the from the and the of the the were with in POVPC and or of the and the were of these was the and and in the and the of was results that of of was in the and the in the that POVPC was in the and The was from the the of of the was associated with of the In the the of found in the to that in was that of the POVPC was in of is of the of the is in of phospholipids in the and and of treatment of POVPC the and the in the and was a in the of with the that by hydrolysis is from the to the these results indicate that in reduction and hydrolysis are the major pathways of POVPC metabolism and that of POVPC is hydrolyzed to of POVPC to PHVPC and lyso-PC be due to pathways or to a of in which to PHVPC or be these the were with pefabloc, of to whether POVPC The of hydrolysis was from the in in the and incubation of reduced the of POVPC In in increased the accumulation of POVPC and leading to increase in the by the of PHVPC in the of POVPC that of hydrolysis the metabolism of POVPC and These are with a in which reduction and hydrolysis are pathways of POVPC metabolism, and of pathway increases metabolism by the pathway the metabolism of POVPC. that POVPC reduction M. K. S. and of with phospholipid PubMed Scopus these (AR) is the major in the of the were with the tolrestat. Treatment with the reduction of POVPC to PHVPC in these cells, by a in the however, a on hydrolysis that POVPC and PHVPC hydrolysis with a and the hydrolysis of POVPC hydrolysis of these that and are the major in the metabolism of POVPC in macrophages and that hydrolysis and reduction with that of hydrolysis increases POVPC The that increased the of POVPC that hydrolysis is a of POVPC Treatment with however, to a increase in POVPC. that is greater it in and or in whether PHVPC is also by to PHVPC is reagent Treatment of with PHVPC led to a of reagent in phospholipids A in PHVPC in the that it is either or whether it is the were with incubation with in treatment with led to of PHVPC in the that POVPC, PHVPC is also by the that POVPC metabolism a comparison of the of of POVPC and PHVPC in that the of of POVPC was that of that POVPC is PHVPC of POVPC lyso-PC and PHVPC that the by metabolism the of the reduction the of the which a to the to the of POVPC, the of POVPC, and lyso-PC in the expression of the cytokine genes. the genes and that were by POVPC in the of in gene in treatment with POVPC led to a increase in the and The increase was with induction of the gene was of treatment with POVPC. The induction of was by and The increase in the expression of all of these genes induction that these were the genes. The of the genes and were increased of a In comparison with POVPC, PHVPC and lyso-PC were in the expression of cytokine genes. in with POVPC was a to increase in and however, in the of the expression of these genes was increased to PHVPC was In with to increase in the expression of and was effects were with cytokine genes. In cells, the expression of was the of Treatment with POVPC led to increase in the expression of the PHVPC was in POVPC. the expression of was increased 2- to in with POVPC or treatment with PHVPC led to increase in the expression of gene with of The greater of PHVPC was also with and POVPC and lyso-PC were incubation with PHVPC led to a to greater increase in the expression of these genes these that PHVPC is POVPC in cytokine genes. is POVPC, it The of POVPC and PHVPC be to their which to these a the effects of upon the to whether the of POVPC and PHVPC is to their of POVPC and PHVPC and in treatment with led to a 2- to increase in the expression of and The of increase in the expression of these genes was to that with POVPC. was in cytokine gene that the of these phospholipids are of the of the the results that the of POVPC are the the of these that of metabolism the proinflammatory effects of POVPC. the effects of POVPC metabolism on cytokine gene these were with either or 1 the of POVPC, and in the expression of the gene were POVPC treatment with POVPC led to a induction of in the of pefabloc, the increase in was greater in the of the that of hydrolysis increases the of POVPC. lyso-PC was POVPC increase in cytokine gene induction be due to the accumulation of POVPC, it be due to increased accumulation of PHVPC In to pefabloc, treatment with led to a in that of PHVPC and the of POVPC, lyso-PC is further that the of POVPC upon PHVPC the were by PHVPC was POVPC in however, in cells, PHVPC was in cells. The increase in the of PHVPC in the of is with the that PHVPC is We that by the of PHVPC and increases cytokine these results with of and that hydrolysis and reduction are pathways of POVPC metabolism and that metabolism of POVPC increases to cytokine genes. with and with of that metabolism effects of the be to the of which to be the major in POVPC metabolism, from the of and AR-null mice. These the of and be in of their and AR-null macrophages were with POVPC, and the induction of and genes was Treatment with POVPC led to increase in and a to increase in and induction was of incubation with POVPC. with increase in the expression of was in AR-null macrophages. the expression of and was increased 2- to 3-fold in AR-null macrophages with cells, the of induction was the to increase with macrophages. These are with the results with the and the that metabolism increases the proinflammatory effects of POVPC. The major of are that the of phospholipid POVPC, increase the expression of and genes in macrophages and that metabolism of these aldehydes increases their proinflammatory We found that macrophages major pathways to metabolize POVPC and phospholipid phospholipids are either reduced by or are hydrolyzed by to of these the proinflammatory effects of of these pathways PHVPC and lyso-PC were found to be in cytokine gene expression POVPC with proinflammatory of PHVPC and found that hydrolysis to accumulation of PHVPC and increase in the induction of cytokine genes, of reduction led to a in the proinflammatory effects of POVPC. that PHVPC was either lyso-PC or however, lyso-PC was POVPC. These the by which oxidized phospholipids inflammation and their proinflammatory effects are regulated by that phospholipid aldehydes oxidation a in S. The of oxidized phospholipids in PubMed Scopus by phospholipid oxidation PubMed Scopus The of with inflammation to of oxidized lipoproteins the PubMed Scopus is vascular inflammation is and by of oxidized phospholipid aldehydes by and of POVPC has been of the major oxidized phospholipids in oxidized M. S. D. et by of oxidized phospholipids in oxidized that and their in PubMed Scopus and a of the G. C. of of oxidized phospholipids. oxidized the PubMed Scopus and S. E. of to of oxidized lipoproteins from mice. of of oxidized in PubMed Scopus S. R.J. and PubMed Scopus S. S. M. C. S. et phospholipids the and of and and cardiovascular results from the PubMed Scopus S. M. M. C. oxidized with of oxidized phospholipids from atherosclerotic lesions a of PubMed Scopus effects of oxidized has a of pathways that are by POVPC and phospholipids S. The of oxidized phospholipids in PubMed Scopus by phospholipid oxidation PubMed Scopus of these pathways to either proinflammatory or In endothelial cells, the oxidized phospholipids increase cytokine production and monocyte with their oxidized phospholipids also E. M. G. S. S. et gene expression by oxidized phospholipids in endothelial and in PubMed Scopus et of a that in to phospholipids 2010; PubMed Scopus in the increase in and also the of by and in of phospholipid oxidation in PubMed Scopus The effects of oxidized phospholipids have been linked to their to to and the that with of phospholipid oxidation in PubMed Scopus C. S. phospholipid of is to and and of PubMed Scopus the the proinflammatory effects of oxidized are of the has been in endothelial in which oxidized phospholipids increase monocyte by that of leading to the of endothelial and protein S. The of oxidized phospholipids in PubMed Scopus In treatment with POVPC has been to increase cytokine production S. D. M. E. POVPC to on macrophages. in PubMed Scopus however, the of In endothelial to by genes M. S. et of gene on of endothelial responses to oxidized PubMed Scopus induction of and genes in metabolism and the protein were pathways of inflammation were In contrast, with macrophages a increase in proinflammatory IL-6, and that a in Thus, be in the in which to oxidized phospholipids. endothelial to by and metabolism, the in macrophages to be increase in the expression of cytokine genes. We found that to POVPC upregulated the genes of was also increase in in of cells, cells, and E. S. The and PubMed Scopus and in and PubMed Scopus or that increase monocyte and in inflammation and PubMed Scopus to POVPC led to a increase in genes in and protein vascular endothelial factor and factor protein and are of that of by by and by of PubMed Scopus also the of and M. D. with a on PubMed Scopus Thus, the effects of the by POVPC in the are likely to in monocyte and the the induction of genes by oxidized phospholipids be by which macrophages to in the and of lesions. of the genes by POVPC are of IL-6, and or are by genes and in to the effects of in endothelial cells, treatment of macrophages with POVPC led to increase in that to oxidized phospholipids. of the genes that were in macrophages are also in in atherosclerotic lesions. of IL-6, and have been in the of atherosclerotic S. and a of in PubMed Scopus The expression of the is in atherosclerotic and has been found to a in in M. in atherosclerotic PubMed Scopus to and of or in accumulation and atherosclerotic in the of vascular PubMed Scopus Thus, to POVPC proinflammatory and responses in macrophages. The of the that the and the of responses by POVPC upon POVPC and phospholipids have which due to by the of in the phospholipid S. M. of oxidized phospholipids in PubMed Scopus The of is also the of oxidized phospholipids by the or M. and of the oxidized phospholipids and oxidized of PubMed Scopus D. D. the of oxidized phospholipids in oxidized lipoproteins by and 2010; PubMed Scopus Thus, in the of the metabolism the of these phospholipids. the be from the phospholipid by or be reduced or In of POVPC, found that hydrolysis and reduction were the major of the metabolism was in although oxidation by in of POVPC and oxidized phospholipids with has been to be by major of the have been The of phospholipase A2 in on in PubMed Scopus The is by of and is associated with lipoproteins The is in and of and E. by factor by metabolism of oxidized phospholipids in PubMed Scopus These with oxidized of phospholipids. In atherosclerotic is associated with macrophages to the or the of the E. phospholipase A2 protein expression in the of PubMed Scopus which the that POVPC is hydrolyzed in macrophages and that hydrolysis is prevented by the pefabloc, indicate that a major in the metabolism of oxidized phospholipids in macrophages. In hydrolysis of POVPC in the of a which was found to be in cytokine production POVPC, that metabolism be in the proinflammatory effects of oxidized In is a of cardiovascular disease of the The of phospholipase A2 in on in PubMed Scopus and it has been that or be a of Treatment of with disease with the has been to the of the a of S. M. D. et of the phospholipase on atherosclerotic PubMed Scopus in a of and treatment with the was found to inflammation and vascular accumulation of C. of phospholipase A2 in and PubMed Scopus In to has also been associated with a in inflammation and a in atherosclerotic gene of in led to a in the of oxidized lipoproteins and a reduction in atherosclerotic in in De D. M. G. C. M. D. et gene of and in PubMed Scopus of the gene the of in in M. S. phospholipase A2 gene in PubMed Scopus and the accumulation of oxidized lipoproteins and inflammation in D. K. expression of accumulation of oxidized lipoproteins and and in in PubMed Scopus In of in death K. K. death by PubMed Scopus from to derived from E. by factor by metabolism of oxidized phospholipids in PubMed Scopus the effects of on inflammation and due to the or the of expression of the and the disease or the and in the in all the of hydrolysis of oxidized phospholipid be a which in is in endothelial M. K. K. in endothelial a protein PubMed Scopus and it by their production of IL-6, and C. of phospholipase A2 in and PubMed Scopus results the of the that lyso-PC is the phospholipid POVPC. that the metabolism increase in macrophages to oxidized phospholipids. the of oxidized phospholipids to their were the that of the responses to oxidized in that the of the hydrolysis of oxidized phospholipids by is to increase have greater inflammation and We found that of increased the accumulation of PHVPC was either lyso-PC or POVPC, it is likely that of inflammation is a pathway of metabolism that the of the oxidized Thus, a from is that is the biochemical pathway the metabolism of oxidized and that be pathways of metabolism that and the effects of oxidized and the of in inflammation and In of pathway was by has and expression of aldose reductase and in and the PubMed Scopus have that and of the are the reduction of POVPC and phospholipid aldehydes M. K. S. and of with phospholipid PubMed Scopus S. M. reduction of PubMed Scopus and it to the metabolism of POVPC in macrophages. In found that the pathway with hydrolysis the POVPC metabolism, the of is also hydrolyzed by Thus, the of POVPC is the with to increase the of the reduction by be a pathway by which the of oxidized phospholipids be The of pathway is with that of D. S. reductase in vascular PubMed Scopus and or inflammation by of aldose reductase expression of in endothelial PubMed Scopus tumor necrosis production is vascular PubMed Scopus or D. and inflammation in is prevented by aldose reductase PubMed Scopus In with these that of led to a of POVPC-induced cytokine the of in cytokine gene expression PHVPC the of the it be that PHVPC is also by the is POVPC and the of the PHVPC likely to with PHVPC be a of these POVPC. that the of PHVPC in macrophages was the of POVPC that PHVPC cause a of POVPC. The of the metabolism of POVPC in is likely to upon the of expression and of and the of of Thus, in with the of inflammation be these also of and In the of the that lyso-PC and PHVPC be In that PHVPC or lyso-PC that metabolism or to in in to the proinflammatory of lyso-PC and PHVPC et that hydrolysis by or reduction by led to a in the of POVPC to G. C. of of oxidized phospholipids. oxidized the PubMed Scopus Thus, it is that the of oxidized phospholipids by and that the in pathways or to to oxidized phospholipids. a the in effects of the oxidized phospholipids on inflammation are to from of in is greater in the in of metabolism and The inflammation and is and although of inflammation in lesions is associated in increase in of inflammation in of in macrophages atherosclerotic E. M. R.J. K. et of in macrophages increases in PubMed Scopus M. phospholipids in and monocyte PubMed Scopus the effects of and in macrophages atherosclerotic is in and it is in S. E. M. K. G. reductase atherosclerotic in PubMed Scopus and gene De D. M. G. C. M. D. et gene of and in PubMed Scopus are to inflammation to atherosclerotic and it is by oxidized phospholipids and regulated by their In the results of that in phospholipid aldehydes POVPC are by pathways by and Products of these pathways and were in the expression of cytokine genes was POVPC. of led to the accumulation of POVPC and PHVPC and increased cytokine gene The induction of cytokine genes was by in macrophages from AR-null mice. These a of the proinflammatory effects of oxidized phospholipids and are regulated by The are to in and to The of the the of is with reductase aldose reductase granulocyte/macrophage colony-stimulating factor interleukin monocyte chemotactic protein 1 phospholipase A2 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine or derived macrophages tumor necrosis factor